Further investigation into the roles of miR-34a, miR-351, and miR-490*, alongside validated genes such as HTR2A, SGPP1, ITGA7, and GANC is essential to elucidate their contributions to early-onset cardiac hypertrophy. The gene discussed is SGPP1; the disease is cardiac hypertrophy.